Transfusion, Mortality Link Varies With Hemoglobin Levels

Share this content:
Transfusion, Mortality Link Varies With Hemoglobin Levels
Transfusion, Mortality Link Varies With Hemoglobin Levels

WEDNESDAY, Dec. 2, 2015 (HealthDay News) -- For critically ill patients, the impact of transfusion on mortality varies with hemoglobin (Hgb) levels and with the presence of comorbid heart disease, according to a study published in the Dec. 8 issue of the Journal of the American College of Cardiology.

Yew Y. Ding, M.B.B.S., M.P.H., from the Tan Tock Seng Hospital in Singapore, and colleagues performed secondary data analyses of Veterans Affairs intensive care unit (ICU) episodes across five years. Logistic regression was used to quantify the effect of transfusion on hospital mortality.

The researchers found that 12.4 percent of the 258,826 ICU episodes involved transfusions; hospital death occurred in 11.6 percent of episodes. Transfusion correlated with decreased adjusted hospital mortality without comorbid heart disease when Hgb was approximately <7.7 g/dL; above this Hgb level, transfusion increased mortality. When comorbid heart disease was present, corresponding Hgb level thresholds were approximately 8.7 g/dL and approximately 10 g/dL when the ICU admission diagnosis was acute myocardial infarction. These thresholds were lowered by about 1 g/dL in sensitivity analyses using additional adjustment for selected blood tests in a subgroup of 182,792 ICU episodes.

"Transfusion of critically ill patients was associated with reduced hospital mortality when Hgb level was <8 to 9 g/dL in the presence of comorbid heart disease," the authors write.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »